发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 119 |
| England | 21 |
| Italy | 19 |
| Canada | 16 |
| Australia | 14 |
| CHINA MAINLAND | 12 |
| Belgium | 11 |
| GERMANY (FED REP GER) | 11 |
| Netherlands | 10 |
| France | 9 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| HARVARD UNIVERSITY | 36 |
| DANA-FARBER CANCER INSTITUTE | 25 |
| UNIVERSITY OF TEXAS SYSTEM | 22 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 19 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 17 |
| BRIGHAM & WOMEN'S HOSPITAL | 14 |
| MAYO CLINIC | 14 |
| YALE UNIVERSITY | 12 |
| UNIVERSITY OF LONDON | 11 |
| INSTITUT JULES BORDET | 10 |
文章引用情况
1
A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis2
Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations3
Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer4
Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women5
Cognitive function following breast cancer treatment and associations with concurrent symptoms6
Success rates of re-excision after positive margins for invasive lobular carcinoma of the breast7
The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer8
Clinical relevance of the 21-gene Recurrence Score (R) assay in treatment decisions for patients with node-positive breast cancer in the genomic era9
Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens10
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer